Shanghai Model Organisms Center Inc (688265) - Total Assets
Based on the latest financial reports, Shanghai Model Organisms Center Inc (688265) holds total assets worth CN¥2.00 Billion CNY (≈ $292.05 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Model Organisms Center Inc - Total Assets Trend (2015–2025)
This chart illustrates how Shanghai Model Organisms Center Inc's total assets have evolved over time, based on quarterly financial data. Also see 688265 company net worth for the company's overall valuation and market capitalisation.
Shanghai Model Organisms Center Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Shanghai Model Organisms Center Inc's total assets of CN¥2.00 Billion consist of 59.6% current assets and 40.5% non-current assets. Review Shanghai Model Organisms Center Inc total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.6% |
| Accounts Receivable | CN¥112.38 Million | 5.7% |
| Inventory | CN¥18.72 Million | 0.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥235.37 Million | 11.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Shanghai Model Organisms Center Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 688265 share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Model Organisms Center Inc's current assets represent 59.6% of total assets in 2025, a decrease from 89.8% in 2015.
- Cash Position: Cash and equivalents constituted 7.6% of total assets in 2025, down from 74.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 4.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 11.9% of total assets.
Shanghai Model Organisms Center Inc Competitors by Total Assets
Key competitors of Shanghai Model Organisms Center Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Abivax SA
PA:ABVX
|
France | €547.14 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE
|
USA | $126.96 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Lifecome Biochemistry Co Ltd
SHE:002868
|
China | CN¥729.16 Million |
|
Pulike Biological Engineering
SHG:603566
|
China | CN¥3.09 Billion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $423.10 Million |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5
|
Germany | €40.03 Million |
Shanghai Model Organisms Center Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.04 | 7.48 | 2.15 |
| Quick Ratio | 4.89 | 7.38 | 2.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥896.72 Million | CN¥1.01 Billion | CN¥124.02 Million |
Shanghai Model Organisms Center Inc - Advanced Valuation Insights
This section examines the relationship between Shanghai Model Organisms Center Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.73 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 2.8% |
| Total Assets | CN¥1.98 Billion |
| Market Capitalization | $593.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Model Organisms Center Inc's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai Model Organisms Center Inc's assets grew by 2.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai Model Organisms Center Inc (2015–2025)
The table below shows the annual total assets of Shanghai Model Organisms Center Inc from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.98 Billion ≈ $290.25 Million |
+2.81% |
| 2024-12-31 | CN¥1.93 Billion ≈ $282.33 Million |
-3.42% |
| 2023-12-31 | CN¥2.00 Billion ≈ $292.34 Million |
-2.72% |
| 2022-12-31 | CN¥2.05 Billion ≈ $300.52 Million |
+4.56% |
| 2021-12-31 | CN¥1.96 Billion ≈ $287.40 Million |
+450.13% |
| 2020-12-31 | CN¥357.02 Million ≈ $52.24 Million |
+63.25% |
| 2019-12-31 | CN¥218.70 Million ≈ $32.00 Million |
+14.09% |
| 2018-12-31 | CN¥191.68 Million ≈ $28.05 Million |
+7.33% |
| 2017-12-31 | CN¥178.59 Million ≈ $26.13 Million |
+18.49% |
| 2016-12-31 | CN¥150.72 Million ≈ $22.05 Million |
+35.59% |
| 2015-12-31 | CN¥111.16 Million ≈ $16.27 Million |
-- |
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. It uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. The company offers toolbox of mice; disease mice, such as rare, infectious, a… Read more